Dr. Lal PathLabs Ltd (DLPA)

NSE


	Symbol		Exchange		Currency
	DLPA		NSE		INR	Real-time
	DLPA		Derived		INR	Real-time
	DLPAc1:NS		NSE		INR	Delayed
	DLPA		BSE		INR	Delayed

Currency in INR

3,018.25

+15.35(+0.51%)

Closed15:29:59

Fair Value

Day's Range

2,984.10

3,028.00

52 wk Range

1,943.70

3,653.95

DLPA Income Statement

Featured here, the Income Statement (earnings report) for Dr. Lal PathLabs Ltd, showing the company's financial performance from operating and non operating activities such as revenue, expenses and income for the last 4 periods (either quarterly or annually).

Advanced Income Statement

Period Ending:

2015

31/03

2016

31/03

2017

31/03

2018

31/03

2019

31/03

2020

31/03

2021

31/03

2022

31/03

2023

31/03

2024

31/03

Total Revenues

13,303.57

15,812.66

20,874.08

20,168.82

22,266.41

Total Revenues Growth

+10.55%

+18.86%

+32.01%

-3.38%

+10.4%

Cost Of Revenues

5,728.47

7,047.46

9,197.63

8,919.58

9,476.11

Gross Profit

7,575.1

8,765.2

11,676.45

11,249.24

12,790.3

Gross Profit Growth

+7.06%

+15.71%

+33.21%

-3.66%

+13.7%

Gross Profit Margin %

56.94%

55.43%

55.94%

55.78%

57.44%

Other Operating Expenses, Total

4,866.01

5,167.4

7,129.37

7,847.71

8,108.82

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+7.69%	+6.19%	+37.97%	+10.08%	+3.33%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2,222.28	2,500.79	3,479.76	3,577.1	4,135.3
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	1,915.63	1,894.63	2,568.54	2,768.68	2,537.55

Operating Income

2,709.09

3,597.8

4,547.08

3,401.53

4,681.48

Operating Income Growth

+5.93%

+32.8%

+26.39%

-25.19%

+37.63%

EBIT Margin %

20.36%

22.75%

21.78%

16.87%

21.02%

Net Interest Expenses

302.62

278.8

170.9

-43.52

260.71

Net Interest Expenses Growth

-24.01%

-7.87%

-38.7%

-125.47%

+699.06%

Interest Expense, Total

-153.12

-159.95

-301.71

-375.3

-293.59

Interest And Investment Income

455.74

438.75

472.61

331.78

554.3

Other Non Operating Expenses, Total

3.37

16.52

1.27

1.02

1.24

EBT, Excl. Unusual Items

3,015.08

3,893.12

4,719.25

3,359.03

4,943.43

Gain (Loss) On Sale Of Assets

1.49

-1.74

-6

8.07

-2.18

Other Unusual Items, Total

5.31

5.42

4.95

6.96

9.29

EBT, Incl. Unusual Items

3,105.03

3,944.09

4,749.82

3,438.27

5,054.51

EBT, Incl. Unusual Items Growth

+3.31%

+27.02%

+20.43%

-27.61%

+47.01%

EBT, Incl. Unusual Items Margin

23.34%

24.94%

22.75%

17.05%

22.7%

Income Tax Expense

829.16

979.3

1,246.91

1,027.5

1,431.58

Net Income to Company

2,275.87

2,964.79

3,502.91

2,410.77

3,622.93

Minority Interest

-16.46

-48.58

-54.58

-22.29

-45.58

Net Income

2,259.41

2,916.21

3,448.33

2,388.48

3,577.35

Net Income Growth

+13.44%

+29.07%

+18.25%

-30.74%

+49.78%

Net Income Margin %

16.98%

18.44%

16.52%

11.84%

16.07%

Preferred Dividend and Other Adjustments

-

-

-

-

-

Net Income to Common Excl. Extra Items

2,259.41

2,916.21

3,448.33

2,388.48

3,577.35

Basic EPS - Continuing Operations

27.42

35.33

41.7

28.82

43.05

Basic EPS - Continuing Operations Growth

+13.33%

+28.84%

+18.04%

-30.88%

+49.34%

Diluted EPS - Continuing Operations

27.37

35.25

41.57

28.74

42.98

Diluted EPS - Continuing Operations Growth

+13.33%

+28.79%

+17.93%

-30.86%

+49.55%

Basic Weighted Average Shares Outstanding

82.4

82.54

82.69

82.86

83.11

Diluted Weighted Average Shares Outstanding

82.55

82.74

82.94

83.12

83.24

Dividend Per Share

12

20

12

12

24

Dividend Per Share Growth

+100%

+66.67%

-40%

0%

+100%

EBITDA

3,076.23

3,988.74

5,188.48

4,412.3

5,672.61

EBITDA Growth

+6.88%

+29.66%

+30.08%

-14.96%

+28.56%

EBITDA Margin %

23.12%

25.22%

24.86%

21.88%

25.48%

EBIT